Hua-Yi Li (Huayi Li)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Patient Reported

Top Venues

NPJ precision oncology

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ping Jin, Xin Li, Yu Xia, Hua-Yi Li, Xiaoting Li, Zong-Yuan Yang, Zhen Wang, Cheng Xu, Tian Fang, Dongchen Zhou, Xiaoming Xiong, Si-Yuan Wang, Sen Xu, Qing-Lei Gao
Bepotastine sensitizes ovarian cancer to PARP inhibitors through suppressing NF-κB-triggered SASP in cancer-associated fibroblasts. Molecular cancer therapeutics (2023)
Jiahong Tan, Xu Zheng, Mengchen Li, Fei Ye, Chunyan Song, Cheng Xu, Xiaoxue Zhang, Wenqian Li, Ya Wang, Shaoqing Zeng, Hua-Yi Li, Gang Chen, Xiao-Yuan Huang, Ding Ma, Dan Liu, Qing-Lei Gao
C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer. Oncogene 40 (22) (2021)
Xiaoting Li, Tian Fang, Sen Xu, Ping Jin, Dongchen Zhou, Zhengzheng Wang, Hua-Yi Li, Zongyuan Yang, Gang Chen, Xu Zheng, Yu Xia, Xiao Wei, Zeyu Zhang, Xin Yang, Ya Wang, Qing-Lei Gao
PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer. NPJ precision oncology 5 (1) (2021)
Yue Gao, Guang-Yao Cai, Wei Fang, Hua-Yi Li, Si-Yuan Wang, Lingxi Chen, Yang Yu, Dan Liu, Sen Xu, Peng-Fei Cui, Shao-Qing Zeng, Xin-Xia Feng, Rui-Di Yu, Ya Wang, Yuan Yuan, Xiao-Fei Jiao, Jian-Hua Chi, Jia-Hao Liu, Ru-Yuan Li, Xu Zheng, Chun-Yan Song, Ning Jin, Wen-Jian Gong, Xing-Yu Liu, Lei Huang, Xun Tian, Lin Li, Hui Xing, Ding Ma, Chun-Rui Li, Fei Ye, Qing-Lei Gao
Machine learning based early warning system enables accurate mortality risk prediction for COVID-19. Nature communications 11 (1) (2020)